Effects of adjuvant tamoxifen therapy on cardiac disease: results from a randomized trial with long-term follow-up. (Q45166351)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23456195%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

title

Effects of adjuvant tamoxifen therapy on cardiac disease: results from a randomized trial with long-term follow-up (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23456195%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

1 reference

1 reference

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23456195%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

author name string

Johan Rosell

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23456195%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Bo Nordenskjöld

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23456195%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Nils-Olof Bengtsson

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23456195%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Tommy Fornander

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23456195%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Thomas Hatschek

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23456195%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Henrik Lindman

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23456195%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Per-Olof Malmström

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23456195%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Arne Wallgren

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23456195%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

Olle Stål

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23456195%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

language of work or name

English

0 references

publication date

2 March 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23456195%20AND%20SRC:MED&resulttype=core&format=json

Breast Cancer Research and Treatment

24 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23456195%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

volume

138

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23456195%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23456195%20AND%20SRC:MED&resulttype=core&format=json

24 February 2020

page(s)

467-473

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23456195%20AND%20SRC:MED&resulttype=core&format=json

Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials

24 February 2020

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2457-6

Meta-analysis of vascular and neoplastic events associated with tamoxifen

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2457-6

Long-term results of tamoxifen prophylaxis for breast cancer--96-month follow-up of the randomized IBIS-I trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2457-6

Coronary heart disease mortality after 5 years of adjuvant tamoxifen therapy: results from a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2457-6

External review and validation of the Swedish national inpatient register

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2457-6

Tamoxifen and cardiac risk factors in healthy women: Suggestion of an anti-inflammatory effect

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2457-6

Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2457-6

Cardiac and thromboembolic morbidity among postmenopausal women with early-stage breast cancer in a randomized trial of adjuvant tamoxifen. The Stockholm Breast Cancer Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2457-6

Tamoxifen for the prevention of breast cancer: current status of the National Surgical Adjuvant Breast and Bowel Project P-1 study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2457-6

Toxicity of adjuvant endocrine therapy in postmenopausal breast cancer patients: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2457-6

Coronary artery disease as the cause of incident heart failure in the population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2457-6

Inflammatory markers and risk of heart failure in elderly subjects without prior myocardial infarction: the Framingham Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2457-6

C-reactive protein, diastolic dysfunction, and risk of heart failure in patients with coronary disease: Heart and Soul Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2457-6

Cardiovascular adverse events during adjuvant endocrine therapy for early breast cancer using letrozole or tamoxifen: safety analysis of BIG 1-98 trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2457-6

Independent risk factors for atrial fibrillation in a population-based cohort. The Framingham Heart Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10549-013-2457-6